Unknown PHASE2 INTERVENTIONAL 2-arm NCT04345770

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Gastric Cancer

A Phase II Study of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the Treatment of Locally Advanced Gastric Cancer

Sponsor: Wuhan University

Conditions Malignant Neoplasm of Stomach

Interventions D2 radical gastrectomy Hyperthermic intraperitoneal chemotherapy (HIPEC) SOX neoadjuvant or postoperative chemotherapy

Updated 5 times since 2020 Last updated: Apr 10, 2020 Started: Apr 1, 2020 Primary completion: Mar 31, 2025 Completion: May 31, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Malignant Neoplasm of Stomach and is currently ongoing. Wuhan University leads this study, which shows 5 recorded versions since 2020 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

Jun 2025 — Present [monthly]

Unknown PHASE2

Status: Recruiting → Unknown
Sep 2024 — Jun 2025 [monthly]

Recruiting PHASE2
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE2
Jan 2021 — Jul 2024 [monthly]

Recruiting PHASE2
May 2020 — Jan 2021 [monthly]

Recruiting PHASE2

First recorded

Apr 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Wuhan University

Data source: Wuhan University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Wuhan, China